Evidence map›Paper›PMID 30679758›Full record

ArticleLaboratory investigation; a journal of technical methods and pathology2019

FOXO3 is involved in the tumor necrosis factor-driven inflammatory response in fibroblast-like synoviocytes.

Bernhard Brandstetter, Karolina Dalwigk, Alexander Platzer, Birgit Niederreiter, Felix Kartnig, Anita Fischer, Gregory I Vladimer, Ruth A Byrne, Florian Sevelda, Johannes Holinka and 6 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Laboratory investigation; a journal of technical methods and pathology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 30 citations in OpenAlex.

  1. Decoding Human Placental Cellular and Molecular Responses to Obesity and Fetal Growth.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Metformin Attenuates ROSFrontiers in immunology · 2021
    Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 2 countries.

Bernhard BrandstetterDivision of Rheumatology, Department of Medicine 3, Medical University of Vienna, 1090, Vienna, Austria.
Karolina DalwigkDivision of Rheumatology, Department of Medicine 3, Medical University of Vienna, 1090, Vienna, Austria.
Alexander PlatzerDivision of Rheumatology, Department of Medicine 3, Medical University of Vienna, 1090, Vienna, Austria.
Birgit NiederreiterDivision of Rheumatology, Department of Medicine 3, Medical University of Vienna, 1090, Vienna, Austria.
Felix KartnigCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090, Vienna, Austria.
Anita FischerDivision of Rheumatology, Department of Medicine 3, Medical University of Vienna, 1090, Vienna, Austria.
Gregory I VladimerCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090, Vienna, Austria.ORCID 0000-0003-4205-7585
Ruth A ByrneDivision of Rheumatology, Department of Medicine 3, Medical University of Vienna, 1090, Vienna, Austria.
Florian SeveldaDepartment of Orthopaedics, Medical University of Vienna, 1090, Vienna, Austria.
Johannes HolinkaDepartment of Orthopaedics, Medical University of Vienna, 1090, Vienna, Austria.
Thomas PapInstitute of Musculoskeletal Medicine, University Hospital Muenster, 48149, Muenster, Germany.
Günter SteinerDivision of Rheumatology, Department of Medicine 3, Medical University of Vienna, 1090, Vienna, Austria.
Giulio Superti-FurgaCeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, 1090, Vienna, Austria.
Josef S SmolenDivision of Rheumatology, Department of Medicine 3, Medical University of Vienna, 1090, Vienna, Austria.
Hans P KienerDivision of Rheumatology, Department of Medicine 3, Medical University of Vienna, 1090, Vienna, Austria.
Thomas KaronitschDivision of Rheumatology, Department of Medicine 3, Medical University of Vienna, 1090, Vienna, Austria. thomas.karonitsch@meduniwien.ac.at.
Medical University of Vienna · ATAustrian Academy of Sciences · ATUniversity Hospital Münster · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fibroblast-like synoviocytes (FLS) are major contributors to joint inflammation in rheumatoid arthritis (RA). Forkhead box O 3 (FOXO3) perturbations in immune cells are increasingly linked to RA pathogenesis. Here, we show that FOXO3 is distinctly inactivated/phosphorylated in the FLS of rheumatoid synovitis. In vitro, stimulation of FLS with tumor necrosis factor-alpha α (TNFα) induced a rapid and sustained inactivation of FOXO3. mRNA profiling revealed that the inactivation of FOXO3 is important for the sustained pro-inflammatory interferon response to TNFα (CXCL9, CXCL10, CXCL11, and TNFSF18). Mechanistically, our studies demonstrate that the inactivation of FOXO3 results from TNF-induced downregulation of phosphoinositide-3-kinase-interacting protein 1 (PIK3IP1). Thus, we identified FOXO3 and its modulator PIK3IP1 as a critical regulatory circuit for the inflammatory response of the resident mesenchymal cells to TNFα and contribute insight into how the synovial tissue brings about chronic inflammation that is driven by TNFα.

Indexed as

AdultAgedAged, 80 and overArthritis, RheumatoidCells, CulturedFemaleFibroblastsForkhead Box Protein O3Gene Expression RegulationHumansInflammationIntracellular Signaling Peptides and ProteinsMaleMembrane ProteinsMiddle AgedSynoviocytesForkhead Box Protein O3Intracellular Signaling Peptides and ProteinsMembrane ProteinsPIK3IP1 protein, humanTumor Necrosis Factor-alpha

Identifiers

PMID30679758
OpenAlexW2912013175

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.